Nathan Vardi is a managing editor at MarketWatch and former senior editor at Forbes. He writes about big money investors, hedge funds, private equity firms, and the intersection of Wall Street and biopharma. He lives in Edgemont, New York.
"A cinematic tour of ambition, greed and desperation in
biotech."
*Mandana Chaffa - Scientific American*
"[For Blood and Money] is a fascinating look at the quest to
develop a new drug for blood cancer that targets only cancerous
cells and not the healthy kind."
*Economist*
"A master class in the machinations of modern drug
development."
*Adrian Woolfson - Science*
"A crash course in biotech success — and failure…. For Blood and
Money does an excellent job of highlighting the complexities and
expense, both financial and personal, of drug development."
*Heidi Ledford - Nature*
"[For Blood and Money ] is much more than a tale of the birth of a
potent new cancer drug, as it reveals the split personality of
biotech: an altruistic enterprise that creates breakthrough
treatments for patients in need, and a bare-knuckle business that
seeks to generate astronomic profits and crush competitors."
*Jerome Groopman - New York Review of Books*
"For Blood and Money is a fascinating—and often disturbing—insider
view of the genesis of a blockbuster drug, and the often-explosive
clash of science, Wall Street cash, ego, and testosterone that are
involved."
*Tom Mueller, author of Extra Virginity and Crisis of
Conscience*
"Nathan Vardi has crafted an intimate and gripping account of the
rollercoaster journey a new drug takes from molecule to potential
medicine. For Blood and Money is a page-turner, chock full of
character and intrigue. With classic journalistic shoe leather,
Vardi delivers the inside story of biotech, bringing readers into
the bare-knuckle backroom of biopharma start-ups where the stakes
couldn’t be higher—especially for patients."
*Charles Graeber, New York Times best-selling author of The Good
Nurse and The Breakthrough*
"Nathan Vardi tells an exciting story of the relentless focus and
extraordinary effort required to bring a breakthrough to patients,
providing rich detail on the delicate interplay between
researchers, biopharma, investors, and regulators that leads to
medical innovation."
*Albert Bourla, CEO of Pfizer*
"A harrowing and improbable story of two rival blockbuster cancer
drugs that takes us deep inside the coiling miasma of high-stakes
modern medicine, where obsessive scientists, doctors, investors,
middlemen, billionaires, and giant corporations alternate,
collaborate, and clash to accomplish what none of them could
possibly do on their own. Meticulously researched, vividly told,
Nathan Vardi’s tale presents a detailed and compelling
portrait."
*Barry Werth, author of The Billion Dollar Molecule and The
Antidote*
"For Blood and Money is a blast. Nathan Vardi shows the roles that
greed, fear, determination, and, above all, ambition play in
developing billion-dollar drugs. A ton of fun and full of
insight."
*Gregory Zuckerman, author of A Shot to Save the World*
"A must-read for anyone who wants to understand how Wall Street
investment leads to the products on pharmacy shelves. Nathan Vardi
brings a deep knowledge and economical storytelling to the clash
between two billionaires behind two cancer drugs and shows real
humanity in describing the scientists who were often caught in the
middle."
*Matthew Herper, Senior Writer, STAT*
"[A] fascinating story of... the financial arrangements, medical
controversies, regulatory processes, and business rivalries without
which the two competing drugs—Imbruvica and Calquence—would not
have become publicly available…. An interesting tale of how
personal ambition, scientific curiosity, and the pursuit of wealth
led to life-extending drugs."
*Kirkus Reviews*
|
Ask a Question About this Product More... |
|
